Do patients with persistent atrial fibrillation have more dispersion of left atrial refractoriness and conduction before development of overt fibrosis?

Abstract Background In patients with persistent atrial fibrillation (PS AF) undergoing pulmonary vein isolation (PVI), left atrial fibrosis, as assessed by voltage mapping prior to ablation, is more common than in patients with paroxysmal (PX) AF. Little is known, however, if subtle changes in left atrial conduction properties, such as conduction time and effective refractory periods (ERP) precede true structural abnormalities and allow to differentiate between PS AF and PX AF. Study aim To test the hypothesis that patients with PS AF demonstrate a larger local left atrial dispersion of conduction and refractoriness, as compared to patients with PX AF. Patients and methods: A total of 49 patients undergoing PVI for symptomatic AF were studied off antiarrhythmic drugs (PX AF, N=35, PS AF [history of cardioversion], N=14). Prior to PVI, a voltage map was performed, using the NAVX™ system and the HD Grid™ mapping catheter. Patients with significant structural heart disease and detectable left atrial fibrosis (voltage < 0.5 mV) were excluded. Local ERP during programmed stimulation was assessed, using the HD Grid™ catheter: On the back of the left atrium, close to the ostium of the left upper pulmonary vein (LUPV), the left lower (LL) PV, the right upper (RU) PV, the right lower (RL) PV, the high interatrial septum (area of Bachmann´s bundle) and the low interatrial septum (between the coronary sinus ostium and the RLPV). The interatrial conduction time was assessed between the HD Grid™ and a catheter in the right atrium. Comparison between groups was performed using the Mann-Whitney U-test. A p value < 0.05 was considered significant Results In this cohort of 49 patients without evidence of overt left atrial fibrosis undergoing ablation for symptomatic AF, no significant differences could be detected between patients with PX AF and PS AF with respect to local dispersion of refractoriness or interatrial conduction. Conclusion In patients with symptomatic AF and no evidence of left atrial fibrosis, local left atrial parameters of refractoriness and conduction did not show any significant differences between the cohort of PS AF and PX AF patients.

Authors

Institutions

Publication Details

Journal
EP Europace
Published
2025-05-01
DOI
https://doi.org/10.1093/europace/euaf085.252
Primary Topic
Cardiovascular Disease and Adiposity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Do patients with persistent atrial fibrillation have more dispersion of left atrial refractoriness and conduction before development of overt fibrosis?

Timothy Andrew Resch, Michael Pfeffer, F Roithinger, Maximilian Tscharre et al.
EP Europace
Cardiovascular Disease and Adiposity
article

Do patients with persistent atrial fibrillation have more dispersion of left atrial refractoriness and conduction before development of overt fibrosis?

Timothy Andrew Resch, Michael Pfeffer, F Roithinger, Maximilian Tscharre, Lukas Fiedler, L Tokarska, Johannes Riedl, F X Roithinger
article en

Abstract

Abstract Background In patients with persistent atrial fibrillation (PS AF) undergoing pulmonary vein isolation (PVI), left atrial fibrosis, as assessed by voltage mapping prior to ablation, is more common than in patients with paroxysmal (PX) AF. Little is known, however, if subtle changes in left atrial conduction properties, such as conduction time and effective refractory periods (ERP) precede true structural abnormalities and allow to differentiate between PS AF and PX AF. Study aim To test the hypothesis that patients with PS AF demonstrate a larger local left atrial dispersion of conduction and refractoriness, as compared to patients with PX AF. Patients and methods: A total of 49 patients undergoing PVI for symptomatic AF were studied off antiarrhythmic drugs (PX AF, N=35, PS AF [history of cardioversion], N=14). Prior to PVI, a voltage map was performed, using the NAVX™ system and the HD Grid™ mapping catheter. Patients with significant structural heart disease and detectable left atrial fibrosis (voltage < 0.5 mV) were excluded. Local ERP during programmed stimulation was assessed, using the HD Grid™ catheter: On the back of the left atrium, close to the ostium of the left upper pulmonary vein (LUPV), the left lower (LL) PV, the right upper (RU) PV, the right lower (RL) PV, the high interatrial septum (area of Bachmann´s bundle) and the low interatrial septum (between the coronary sinus ostium and the RLPV). The interatrial conduction time was assessed between the HD Grid™ and a catheter in the right atrium. Comparison between groups was performed using the Mann-Whitney U-test. A p value < 0.05 was considered significant Results In this cohort of 49 patients without evidence of overt left atrial fibrosis undergoing ablation for symptomatic AF, no significant differences could be detected between patients with PX AF and PS AF with respect to local dispersion of refractoriness or interatrial conduction. Conclusion In patients with symptomatic AF and no evidence of left atrial fibrosis, local left atrial parameters of refractoriness and conduction did not show any significant differences between the cohort of PS AF and PX AF patients.

EP EuropaceVol. 27(Supplement_1)
Landesgesundheitsamt Baden-Württemberg (DE)
Openalex Percentile: Top 79%
Cardiovascular Disease and Adiposity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.